Beyond the buzz...
Having worked at the intersection of digital and pharma since 2008 (before it was sexy), I've had the opportunity to engage many talented...
top of page
Blackletter
Group
- 2 min
why should we invest in digital?
“Why should we invest in a digital therapeutic when it will never come close to generating the revenue we make from our drug portfolio?...
- 2 min
digital health is losing credibility
“It’s been 3 years of strategizing, ideating and experimenting with very little impact - unfortunately, our digital health folks have...
- 2 min
specificity wins the day!
Imagine going for a hike and accidentally falling into a deep hole you can’t climb out of. You look up but all you see is blue sky and...
- 1 min
do digital therapeutics work?
I’ve noticed a significant increase in conversations about how to best evaluate the efficacy of digital therapeutics (e.g., do they...
- 2 min
"ai" is so much hype...
“Miron, these AI tools aren’t doing the things we want them to do” I love separating hype from what’s real and a recent dinner with a...
- 2 min
can digital health scale?
“We worked on a digital health project that was moving at lightning speed with a small team, and at some point, we shared it with the...
- 2 min
finding "deep edge"
I've recently noticed more tech scouting requests come in from of our Pharma clients. What's interesting is that while they often have...
- 1 min
medical affairs and digital affairs
“The pandemic has made it more difficult to engage with physicians in a meaningful way. Sending them a pdf of our recent study and...
- 2 min
using ai for bad...
What happens when AI drug discovery tools are (mis)used to find the most lethal human toxins instead of new therapies? In this “thought...
bottom of page